AB0510 Monitoring disease activity and response through power doppler ultrasonography in rheumatoid arthritis patients treated with rituximab – correlations with antibodies pannel

Abstract

BackgroundRituximab is a a chimeric anti-CD20 monoclonal antibody approved to reduce the signs and symptoms of moderately to severely active rheumatoid arthritis (RA) in patients with inadequate response to first...